Table 3 Acute and late toxicity according to the type of radiotherapy (3D-CRT vs. IMRT/Tomotherapy)
From: Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
3D-CRT | IMRT/Tomotherapy | |||
|---|---|---|---|---|
G0/G1 | G2/3 | G0/1 | G2/3 | |
Acute toxicity | ||||
Radiodermatitis | 2 (5.4%) | 35 (94.6%) | 25 (36.8%) | 43 (63.2%) |
Urinary tract (dysuria) | 29 (78.4%) | 8 (21.6%) | 55 (80.9%) | 13 (19.1%) |
Gastrointestinal (diarrhea) | 12 (32.4%) | 25 (67.6%) | 36 (52.9%) | 32 (47.1%) |
Genital tract [female] (colpitis) | 27 (73.0%) | 10 (27.0%) | 51 (75.0%) | 17 (25.0%) |
Late toxicity | ||||
Urinary tract (dysuria) | 36 (97.3%) | 1 (2.7%) | 66 (97.1%) | 2 (2.9%) |
Gastrointestinal (incontinence) | 35 (94.6%) | 2 (5.4%) | 68 (100%) | 0 |
Genital tract [female] (atrophy of vaginal mucosa) | 31 (83.8%) | 6 (16.2%) | 57 (83.8%) | 11 (16.2%) |
Genital tract [male] (impotence) | 37 (100%) | 0 | 68 (100%) | 0 |